The development of novel carriers for gene therapy of tumors

Información del proyecto

JOANNA REJMAN

Identificador del acuerdo de subvención: QLG1-CT-1999-51493

Proyecto cerrado

Fecha de inicio 1 Julio 2000

Fecha de finalización 30 Junio 2002

Financiado con arreglo a

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coste total € 140 600,00

Aportación de la UE € 140 600,00

Coordinado por

UNIVERSITY OF GRONINGEN
Netherlands

Objetivo

The purpose of this project is to develop novel synthetic amphiphile formulations, which express a higher delivery efficiency and cell/tissue specificity. The next step will be applying the systems as developed in a comparative study that relies upon gene expression in vitro versus in vivo.

Ámbito científico

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy

Programa(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Tema(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Convocatoria de propuestas

Data not available

Régimen de financiación

RGI - Research grants (individual fellowships)

Coordinador

UNIVERSITY OF GRONINGEN

• Aportación de la UE: Sin datos
• Dirección: Antonius Deusinglaan 1 ; 9713 AV GRONINGEN ; Países Bajos
• Coste total: Sin datos